U.S. flag

An official website of the United States government

NM_033380.3(COL4A5):c.449_450delinsAT (p.Gly150Asp) AND X-linked Alport syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 28, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004555479.2

Allele description [Variation Report for NM_033380.3(COL4A5):c.449_450delinsAT (p.Gly150Asp)]

NM_033380.3(COL4A5):c.449_450delinsAT (p.Gly150Asp)

Gene:
COL4A5:collagen type IV alpha 5 chain [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
Xq22.3
Genomic location:
Preferred name:
NM_033380.3(COL4A5):c.449_450delinsAT (p.Gly150Asp)
HGVS:
  • NC_000023.11:g.108571821_108571822delinsAT
  • NG_011977.2:g.136898_136899delinsAT
  • NM_000495.5:c.449_450delinsAT
  • NM_033380.3:c.449_450delinsATMANE SELECT
  • NP_000486.1:p.Gly150Asp
  • NP_203699.1:p.Gly150Asp
  • LRG_232t1:c.449_450delinsAT
  • LRG_232t2:c.449_450delinsAT
  • LRG_232:g.136898_136899delinsAT
  • LRG_232p1:p.Gly150Asp
  • LRG_232p2:p.Gly150Asp
  • NC_000023.10:g.107815051_107815052delinsAT
Protein change:
G150D
Molecular consequence:
  • NM_000495.5:c.449_450delinsAT - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033380.3:c.449_450delinsAT - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
X-linked Alport syndrome (ATS1)
Synonyms:
NEPHROPATHY AND DEAFNESS, X-LINKED; Alport syndrome 1, X-linked recessive; Alport Syndrome and Thin Basement Membrane Nephropathy
Identifiers:
MONDO: MONDO:0010520; MedGen: C4746986; Orphanet: 63; Orphanet: 88917; OMIM: 301050

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005044454MVZ Medizinische Genetik Mainz
criteria provided, single submitter

(UK Practice Guidelines For Variant Classification V4 01 2020)
Likely pathogenic
(Feb 28, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Details of each submission

From MVZ Medizinische Genetik Mainz, SCV005044454.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

ACMG Criteria: PM2_SUP, PP3, PP4, PM5, PM1

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Jun 2, 2024